Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL6 Assay for Predicting Weaning Failure in COVID-19 ARDS
NCT05330845Terminated
- Sponsor
- Centre Hospitalier d'Avignon
- Start
- Aug 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier d'Avignon. Primary endpoint: Serum concentration of IL6. Started Aug 2021; status: terminated.
Beyond the preview
Go deeper on NCT05330845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330845.